Science
Mechanism of Action
This extract exerts its biological effects through a multifaceted action, providing antiviral, anti-inflammatory, antiseptic, and antibacterial benefits that contribute to skin purification and the management of microbial or viral skin conditions. Additionally, its antioxidant capacity aids in safeguarding dermal integrity by mitigating oxidative stress induced by environmental aggressors.
Research
Clinical Evidence
Medium confidence1-2%
Key findings
- 01 Clinical insights indicate that Ravensara essential oil is effectively diluted at 1-2% for extensive cutaneous applications, such as general body massage. Higher concentrations, up to 5-10%, are considered for highly localized, short-duration applications on minimal skin areas, particularly for conditions like herpes or shingles.
Transparency
Dusting Analysis
Ravensara Aromatica Twig Extract, being a potent essential oil, carries a significant risk of irritation and sensitization at elevated concentrations. Consequently, it is imperative that formulations intended for broad cutaneous application do not exceed a 1-2% concentration to ensure consumer safety and product integrity.
The Formula
Formulation
Stability
The extract demonstrates stability under recommended handling and storage conditions. It is insoluble in water but exhibits solubility in alcohol and various oils, making it suitable for incorporation into anhydrous or emulsion-based systems.
Conflicts
- High concentrations (leading to irritation and sensitization)
- Direct contact with mucous membranes and eyes without appropriate dilution
Safety
Safety Profile
Ravensara Aromatica Twig Extract has not undergone specific safety review by CIR, SCCS, or FDA for cosmetic use beyond its designation as a fragrance agent. However, Safety Data Sheets for the related Ravensara Aromatica Leaf Oil classify it as a Category 2 skin irritant, Category 1 skin sensitizer, Category 2 germ cell mutagen, and Category 2 carcinogen. It contains known allergens including limonene, methyl-eugenol, methyl-chavicol, and estragole. Due to its inherent potency, heavy dilution, with a recommended maximum of 1-2% for general cutaneous application, is crucial to mitigate risks of irritation and sensitization. Furthermore, its use is contraindicated during pregnancy, breastfeeding, and for children under 6 years of age, primarily due to its estragole content. Comprehensive patch testing is strongly advised prior to application.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While offering diverse beneficial properties for problematic skin, its significant safety profile, including classifications as an irritant, sensitizer, and potential mutagen/carcinogen, necessitates extreme caution and strict adherence to low dilution rates in cosmetic formulations.
Related
Similar Ingredients
Finding similar ingredients…